Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel A Pollyea

Showing results (21-30 of 179) with videos related to

Pageof 18
Sort By:
Haematologica|August 16, 2023
Molecular measurable residual disease: staring at red herringsAmanda C Winters, Daniel A Pollyea
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2018
Targeting the <i>IDH2</i> Pathway in Acute Myeloid LeukemiaMaria L Amaya, Daniel A Pollyea
Current Hematologic Malignancy Reports|September 12, 2014
Stopping higher-risk myelodysplastic syndrome in its tracksDaniel A Pollyea, Jonathan A Gutman
Leukemia|October 20, 2019
How we use venetoclax with hypomethylating agents for the treatment of newly diagnosed patients with acute myeloid leukemiaBrian A Jonas, Daniel A Pollyea
Cancer Control : Journal of the Moffitt Cancer Center|October 1, 2013
Expert insights into the contemporary management of older adults with acute myeloid leukemiaFarhad Ravandi, Harry P Erba, Daniel A Pollyea
British Journal of Haematology|February 15, 2011
Acute myeloid leukaemia in the elderly: a reviewDaniel A Pollyea, Holbrook E Kohrt, Bruno C Medeiros
The Lancet. Haematology|November 26, 2020
Complete, yet partial: the benefits of complete response with partial haematological recovery as an endpoint in acute myeloid leukaemia clinical trialsRory M Shallis, Daniel A Pollyea, Amer M Zeidan
Best Practice & Research. Clinical Haematology|December 14, 2022
Recent progress in acute leukemia and myelodysplasiaHetty E Carraway, Daniel A Pollyea, Eytan M Stein
Blood Reviews|February 3, 2021
The complete story of less than complete responses: The evolution and application of acute myeloid leukemia clinical responsesRory M Shallis, Daniel A Pollyea, Amer M Zeidan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2010
Utility of influenza vaccination for oncology patientsDaniel A Pollyea, Janice M Y Brown, Sandra J Horning
Pageof 18

Showing results (21-30 of 179) with videos related to

Sort By:
Pageof 18
Haematologica|August 16, 2023
Molecular measurable residual disease: staring at red herringsAmanda C Winters, Daniel A Pollyea
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2018
Targeting the <i>IDH2</i> Pathway in Acute Myeloid LeukemiaMaria L Amaya, Daniel A Pollyea
Current Hematologic Malignancy Reports|September 12, 2014
Stopping higher-risk myelodysplastic syndrome in its tracksDaniel A Pollyea, Jonathan A Gutman
Leukemia|October 20, 2019
How we use venetoclax with hypomethylating agents for the treatment of newly diagnosed patients with acute myeloid leukemiaBrian A Jonas, Daniel A Pollyea
Cancer Control : Journal of the Moffitt Cancer Center|October 1, 2013
Expert insights into the contemporary management of older adults with acute myeloid leukemiaFarhad Ravandi, Harry P Erba, Daniel A Pollyea
British Journal of Haematology|February 15, 2011
Acute myeloid leukaemia in the elderly: a reviewDaniel A Pollyea, Holbrook E Kohrt, Bruno C Medeiros
The Lancet. Haematology|November 26, 2020
Complete, yet partial: the benefits of complete response with partial haematological recovery as an endpoint in acute myeloid leukaemia clinical trialsRory M Shallis, Daniel A Pollyea, Amer M Zeidan
Best Practice & Research. Clinical Haematology|December 14, 2022
Recent progress in acute leukemia and myelodysplasiaHetty E Carraway, Daniel A Pollyea, Eytan M Stein
Blood Reviews|February 3, 2021
The complete story of less than complete responses: The evolution and application of acute myeloid leukemia clinical responsesRory M Shallis, Daniel A Pollyea, Amer M Zeidan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2010
Utility of influenza vaccination for oncology patientsDaniel A Pollyea, Janice M Y Brown, Sandra J Horning
Pageof 18